Skip to main content
Top
Published in: Journal of Ophthalmic Inflammation and Infection 2/2012

Open Access 01-06-2012 | Editorial

Surveying uveitis specialists—a call for consensus

Author: Emmett T. Cunningham Jr.

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 2/2012

Login to get access

Excerpt

In the early 1990s, former Michigan supreme court Justice Thomas Brennan became disillusioned with popular law school rankings and so decided to survey 100 academics, judges, and lawyers on his own, asking them to rank a list of ten schools he provided. He used a composite index similar in structure, but different in content, to those used by mainstream surveyors, such as U.S. News & World Report. As expected, many of the big name schools—Harvard, Yale, Stanford—made it to the top of the list. Penn State, as Brennan recalled, “[Was] about in the middle of the pack. Maybe fifth among the 10 schools listed.” There was one small problem, however. Penn State had no law school at the time. Brennan had included it to make a point: surveys are limited by both the quality of the questions asked and by how familiar respondents are with the subject being surveyed [1, 2]. …
Literature
1.
go back to reference Gibeaut J (1996) Rank speculation. Some big-name law schools fare poorly in new, controversial by a former Michigan justice. ABA J 42–43 Gibeaut J (1996) Rank speculation. Some big-name law schools fare poorly in new, controversial by a former Michigan justice. ABA J 42–43
2.
go back to reference Gladwell M (2011) The order of things. What college rankings really tell us. The New Yorker, February 14 & 21, 2011, 68–75 Gladwell M (2011) The order of things. What college rankings really tell us. The New Yorker, February 14 & 21, 2011, 68–75
3.
go back to reference McColl E, Jacoby A, Thomas L, Soutter J, Bamford C, Steen N, Thomas R, Harvey E, Garratt A, Bond J (2001) Design and use of questionnaires: a review of best practices applicable to surveys of health service staff and patients. Health Technol Assess 5–31 McColl E, Jacoby A, Thomas L, Soutter J, Bamford C, Steen N, Thomas R, Harvey E, Garratt A, Bond J (2001) Design and use of questionnaires: a review of best practices applicable to surveys of health service staff and patients. Health Technol Assess 5–31
4.
go back to reference Hing CB, Smith TO, Hooper L, Song F, Donell ST (2011) A review of how to conduct a surgical survey using a questionnaire. Knee 18(4):209–213PubMedCrossRef Hing CB, Smith TO, Hooper L, Song F, Donell ST (2011) A review of how to conduct a surgical survey using a questionnaire. Knee 18(4):209–213PubMedCrossRef
5.
go back to reference Engstrom RE Jr, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111(5):601–610PubMedCrossRef Engstrom RE Jr, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111(5):601–610PubMedCrossRef
6.
go back to reference Cunningham ET Jr, Hubbard LD, Danis RP, Holland GN (2011) Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis. Arch Ophthalmol 129(11):1507–1508PubMedCrossRef Cunningham ET Jr, Hubbard LD, Danis RP, Holland GN (2011) Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis. Arch Ophthalmol 129(11):1507–1508PubMedCrossRef
7.
go back to reference Holland GN, Lewis KG (2002) An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134(6):102–114PubMedCrossRef Holland GN, Lewis KG (2002) An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134(6):102–114PubMedCrossRef
8.
go back to reference Wakefiled D, Cunningham ET Jr, Pavesio C, Garweg JG, Zierhut M (2011) Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm 19(1):2–9CrossRef Wakefiled D, Cunningham ET Jr, Pavesio C, Garweg JG, Zierhut M (2011) Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm 19(1):2–9CrossRef
9.
go back to reference Lum F, Jones JL, Holland GN, Liesegang TJ (2005) Survey of ophthalmologists about ocular toxoplasmosis. Am J Ophthalmol 140(4):724–727PubMedCrossRef Lum F, Jones JL, Holland GN, Liesegang TJ (2005) Survey of ophthalmologists about ocular toxoplasmosis. Am J Ophthalmol 140(4):724–727PubMedCrossRef
10.
go back to reference Nguyen QD, Hatef E, Kayen B, Macahilig CP, Ibrahim M, Wang J, Shaikh O, Bodaghi B (2011) A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology 118(1):184–190PubMedCrossRef Nguyen QD, Hatef E, Kayen B, Macahilig CP, Ibrahim M, Wang J, Shaikh O, Bodaghi B (2011) A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology 118(1):184–190PubMedCrossRef
11.
go back to reference Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513PubMedCrossRef Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513PubMedCrossRef
12.
go back to reference Esterberg E, Acharya NR (2011) Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect (in press) Esterberg E, Acharya NR (2011) Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect (in press)
13.
go back to reference Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH (2009) Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Methotrexate for ocular inflammatory diseases. Ophthalmology 116(11):2188-98.e1 Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH (2009) Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Methotrexate for ocular inflammatory diseases. Ophthalmology 116(11):2188-98.e1
14.
go back to reference Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH (2010) Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 149(3):423–432.e1-2 Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH (2010) Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 149(3):423–432.e1-2
15.
go back to reference Cunningham ET Jr, Goldstein DA, Zierhut M. Uveitis treatment trials – A cross trial perspectives. Ocul Immunol Inflamm 2012; 20(2):63–67 Cunningham ET Jr, Goldstein DA, Zierhut M. Uveitis treatment trials – A cross trial perspectives. Ocul Immunol Inflamm 2012; 20(2):63–67
16.
go back to reference Goldstein DA, Fontanilla FA, Kaul S, Sahin O, Tessler HH (2002) Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology 109:370–377PubMedCrossRef Goldstein DA, Fontanilla FA, Kaul S, Sahin O, Tessler HH (2002) Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology 109:370–377PubMedCrossRef
17.
go back to reference Birnbaum AD, Oh F, Sahin O, Little DM, Tessler HH, Goldstein DA (2010) Chlorambucil and malignancy. Ophthalmology 117(7):1466–1466.e1 Birnbaum AD, Oh F, Sahin O, Little DM, Tessler HH, Goldstein DA (2010) Chlorambucil and malignancy. Ophthalmology 117(7):1466–1466.e1
18.
go back to reference Zaghetto JM, Yamamoto MM, Souza MB, Silva FT, Hirata CE, Olivalves E, Yamamoto JH (2010) Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study. Arq Bras Oftalmol 73(1):40–46PubMedCrossRef Zaghetto JM, Yamamoto MM, Souza MB, Silva FT, Hirata CE, Olivalves E, Yamamoto JH (2010) Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study. Arq Bras Oftalmol 73(1):40–46PubMedCrossRef
19.
20.
go back to reference Hemmati HD, Dunn JP (2010) Biologic therapy for uveitis. Expert Rev Ophthalmol 5(2):225–239CrossRef Hemmati HD, Dunn JP (2010) Biologic therapy for uveitis. Expert Rev Ophthalmol 5(2):225–239CrossRef
21.
22.
go back to reference Heiligenhaus A, Thurau S, Hennig M, Grajewski RS, Wildner G (2011) Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefes Arch Clin Exp Ophthalmol 248(11):1531–1551CrossRef Heiligenhaus A, Thurau S, Hennig M, Grajewski RS, Wildner G (2011) Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefes Arch Clin Exp Ophthalmol 248(11):1531–1551CrossRef
24.
go back to reference Benitah NR, Sobrin L, Papaliodis GN (2011) The use of biologic agents in the treatment of ocular manifestations of Behcet's disease. Semin Ophthalmol 26(4–5):295–303PubMedCrossRef Benitah NR, Sobrin L, Papaliodis GN (2011) The use of biologic agents in the treatment of ocular manifestations of Behcet's disease. Semin Ophthalmol 26(4–5):295–303PubMedCrossRef
25.
go back to reference Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I (2010) Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum 62(9):2796–2805PubMedCrossRef Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I (2010) Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum 62(9):2796–2805PubMedCrossRef
26.
go back to reference Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB 3rd, Thorne JE (2008) Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 115(10):1826–1832PubMedCrossRef Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB 3rd, Thorne JE (2008) Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 115(10):1826–1832PubMedCrossRef
27.
go back to reference Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS (2010) Cyclosporine for ocular inflammatory diseases. Ophthalmology 117(3):576–584PubMedPubMedCentralCrossRef Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS (2010) Cyclosporine for ocular inflammatory diseases. Ophthalmology 117(3):576–584PubMedPubMedCentralCrossRef
28.
go back to reference Smith JR, Jabs DA, Briceland DJ, Holland GN (2008) Education in the ophthalmic discipline of uveitis. Am J Ophthalmol 146(6):799–801PubMedCrossRef Smith JR, Jabs DA, Briceland DJ, Holland GN (2008) Education in the ophthalmic discipline of uveitis. Am J Ophthalmol 146(6):799–801PubMedCrossRef
29.
go back to reference Vakil N (2011) Consensus guidelines: method or madness? Am J Gastroenterol 106(2)S:225–227 Vakil N (2011) Consensus guidelines: method or madness? Am J Gastroenterol 106(2)S:225–227
30.
go back to reference Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease Am J Ophthalmol 136(6):973–988PubMed Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease Am J Ophthalmol 136(6):973–988PubMed
31.
go back to reference Holland GN (2004) Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management Am J Ophthalmol 137(1):1–17PubMed Holland GN (2004) Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management Am J Ophthalmol 137(1):1–17PubMed
Metadata
Title
Surveying uveitis specialists—a call for consensus
Author
Emmett T. Cunningham Jr.
Publication date
01-06-2012
Publisher
Springer Berlin Heidelberg
Published in
Journal of Ophthalmic Inflammation and Infection / Issue 2/2012
Electronic ISSN: 1869-5760
DOI
https://doi.org/10.1007/s12348-012-0061-2

Other articles of this Issue 2/2012

Journal of Ophthalmic Inflammation and Infection 2/2012 Go to the issue